Clinical trial
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for…
NCT00004143 · David Rizzieri, MD, Other · Completed
Key facts
| NCT number | NCT00004143 |
|---|---|
| Title | Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes |
| Official title | Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes |
| Lead sponsor | David Rizzieri, MD, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia, Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Pure Red Cell Aplasia |
| Intervention type | Drug |
| Interventions | Campath, Chemo and/or TBI Allo SCT |
| Enrollment | 2 |
| Start date | Sep 1, 1999 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: